| http://www.w3.org/ns/prov#value | - ???This disease, particularly in patients whose tumors carry multiple copies of the MYCN oncogene, has a particularly poor prognosis and new therapies are urgently needed,??? said Michelle Haber, Ph.D., professor and executive director of Children???s Cancer Institute Australia for Medical Research in Sydney, Australia. ???Our findings suggest that MYCN-driven over-expression of ODC1 in this disea
|
